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PleurisySeveral emerging lines of evidence support an anti-inﬂammatory role for nicotinamide and other vitamin B
components. However, themechanisms underlying their activity remain unclear. In the present study, we inves-
tigated the ability of nicotinamide to inhibit both neutrophil recruitment in IL-8-, LTB4- or carrageenan-induced
pleurisy in mice and the rolling and adherence of neutrophils. Nicotinamide inhibited IL-8-, LTB4- and
carrageenan-induced neutrophil migration, KC production and carrageenan-induced neutrophil rolling and ad-
herence. We propose that the effects of nicotinamide in inhibiting neutrophil recruitment in carrageenan-
induced pleurisy may be due to the ability of nicotinamide to inhibit the action of IL-8 and LTB4, decrease KC
production, and inhibit early events that regulate leukocyte migration from blood vessels into tissue.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Neutrophils are circulating cells that are recruited from blood ves-
sels into inﬂamed tissues in response to chemoattractants released at
the site of injury. Studies of chemoattractant agents show amajor role
for the CXC chemokines CXCL-8/interleukin (IL-)8, keratinocyte-
derived chemokine (KC/CXCL1, a mouse homologue of human IL-8),
and lipopolysaccharide-induced CXC chemokine (LIX/CXCL5) and
lipid mediators such as leukotriene (LT)B4, which act directly on the
surface of neutrophils to induce recruitment in vivo (Baggiolini et
al., 1989; Kobayashi, 2008; Samuelsson, 1983; Smith et al., 2008).
At the site of injury, neutrophil accumulation plays an important
role in tissue damage by releasing proteases contained within their
azurophilic granules, such as neutrophil elastase, cathepsin G and
proteinase-3 (Faurschou and Borregaard, 2003; Korkmaz et al.,
2010), lysosomal enzymes, and reactive oxygen species that in turn
promote lesions in surrounding tissues and contribute to the severity
of inﬂammatory disease (Kobayashi and DeLeo, 2009; Weiss, 1989).
Thus, a better understanding of the pathways and chemoattractant
molecules required for neutrophil migration from the blood vesselsacologia, Instituto de Ciências
ntônio Carlos, 6627 Pampulha,
1 34092711; fax: +55 021 31
evier OA license.to the inﬂamed tissues may aid in the development of new therapeu-
tic strategies for the treatment of inﬂammatory diseases.
Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme that
transfers adenosine diphosphate-ribose units from nicotinamide ade-
nine dinucleotide (NAD+) to nuclear proteins, thereby regulating
gene expression, DNA repair and apoptosis (Ziegler, 2000). There are
several lines of evidence supporting a role for PARP-1 activation in the
development of an inﬂammatory response (Hassa and Hottiger, 2002;
Szabo et al., 1997). PARP-1 regulates the function of several transcrip-
tion factors, including enhancing nuclear factor kappa B (NF-κB)-
mediated transcription, and NF-κB is a cellular pro-inﬂammatory pro-
tein implicated in the expression of inﬂammatory mediators (Virag
and Szabo, 2002). The inﬂammatory role of PARP-1 is further supported
by studies fromOliver et al. (1999) demonstrating that PARP-1-deﬁcient
mice exhibit reduced expression of NF-κB and other inﬂammatory
mediators, including nitric oxide, tumor necrosis factor (TNF)-α and
interferon (IFN)-γ, and reduced cytokine production (Oliver et al., 1999).
Nicotinamide, a component of vitamin B3, is the amide of nicotinic
acid, a PARP-1 inhibitor and a precursor of NAD+, and thus controls
the cellular levels of PARP-1 and consequently the cellular alterations
induced by PARP-1, including those related to establishing inﬂamma-
tion resulting from the excessive activation of this enzyme (PARP-1).
Thus, it has been suggested that nicotinamide may contribute to the
control of inﬂammatory diseases (Uchigata et al., 1982). Although
there is evidence supporting a role for nicotinamide in the control
of inﬂammation, its role in neutrophil recruitment and the mecha-
nisms underlying its involvement in neutrophil recruitment as well
as its relevance to the modulation of microvascular events leading
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main to be elucidated. In the present study, we evaluated the effects
of nicotinamide in carrageenan-induced neutrophil recruitment, neu-
trophil rolling and adherence.
2. Materials and methods
2.1. Reagents
Nicotinamide, carrageenan, zymosan and carboxymethylcellulose
were purchased from Sigma (St. Louis, MO). Nicotinamide was pre-
pared in a 0.5% carboxymethylcellulose sodium salt suspension in
saline immediately before the experiments, and the volume of per
os (p.o.) administration of nicotinamide was 8 ml/kg. Leukotriene
B4 (LTB4) was purchased from Cayman Chemical (Ann Arbor, MI,
USA), and recombinant human IL-8 and murine KC ELISA kit were
obtained from Peprotech (Rock Hill, NJ, USA). Carrageenan, IL-8,
zymosan and LTB4 were dissolved in PBS (pH 7.4). IL-8 was dissolved
in PBS containing 0.01% bovine serum albumin (Sigma). LTB4 and
IL-8 were dissolved as 1 mg/ml ﬁnal stock solutions and stored at
−20 °C until use. The endotoxin level in the IL-8 solution was
b0.1 ng/μg protein (maximal injection into the peritoneal cavity of
contaminating LPS was 0.01 ng) and was much lower than the dose
of endotoxin needed to induce neutrophil migration in the model
(>50 ng/cavity). Control mice received drug vehicle.
2.2. Animals
Male BALB/c mice (18–22 g) were used throughout these experi-
ments. Animals were housed in a temperature-controlled room with
free access to food and water. Throughout the experiments, the
animals were managed in accordance with the principles and guide-
lines for the care of laboratory animals, and the experimental proce-
dures were previously approved by the Ethics Committee on Animal
Experimentation (CETEA, protocol no. 24/2011) of the Federal University
of Minas Gerais (UFMG).
2.3. Carrageenan-, zymosan- or neutrophil chemoattractant-induced
leukocyte migration into the pleural cavity
Carrageenan (200 μg/0.1 ml/cavity), zymosan (200 μg/0.1 ml/cavity),
IL-8 (60 ng/0.1 ml/cavity), LTB4 (500 ng/0.1 ml/cavity) or vehicle (PBS/
0.1 ml/cavity) were injected intrapleurally (i.pl.) into mice, which were
sacriﬁced in a CO2 chamber 4 h after the i.pl. injection. The cells present
in the cavity were harvested by injecting 2 ml PBS, and total cell counts
were performed in a modiﬁed Neubauer chamber using Turk's stain
(Klein et al., 2001). Differential cell counts were performed on cytospin
preparations, which were stained with May–Grunwald and Giemsa to
identify cell types according to standardmorphologic criteria. The results
are presented as the number of cells per cavity. The dose of LTB4 used in
this study was previously shown to effectively induce in vivo leukocyte
recruitment in the same pleurisy model (Klein et al., 2001), and the
IL-8 dose used was based on a previous study of in vivo neutrophil re-
cruitment (Ramos et al., 2003).
2.4. Effects of nicotinamide treatment on carrageenan-, zymosan-,
IL-8- or LTB4-induced neutrophil recruitment
To evaluate the effects of nicotinamide treatment on the neutrophil
recruitment induced by carrageenan (200 μg/cavity), zymosan (200 μg/
cavity), IL-8 (60 ng/cavity) or LTB4 (500 ng/cavity), mice were treated
p.o. with nicotinamide (250, 500 or 1000 mg/kg) or with vehicle
(carboxymethylcellulose) twice, 0.5 h before and 1 h after the i.pl.
injection of inﬂammatory stimuli. In some experiments, mice were
post-treated with nicotinamide (250, 500 or 1000 mg/kg) 2 h after thecarrageenan (200 μg/cavity) i.pl. injection. The number of inﬁltrating
neutrophilswas assessed 4 h after the injection of inﬂammatory stimuli.2.5. Effects of nicotinamide on carrageenan-induced neutrophil recruitment
in intravital studies of cremaster muscle microcirculation
To study the effects of nicotinamide on the behavior of leukocytes
in the microcirculation and adjacent connective tissue, we performed
intravital studies in a mouse cremaster muscle preparation, as de-
scribed previously (Kubes et al., 1991). The mouse cremaster muscle
preparation is a very well-established preparation that has been used
to study the skeletal muscle microcirculation in intravital studies
(Hickey et al., 1997; Kunkel et al., 1996; Vicaut and Stucker, 1990),
allowing the visualization and quantiﬁcation in real time of rolling
leukocytes and adherent leukocytes to the vascular endothelium.
Mice were gently restricted and treated with nicotinamide
(1000 mg/kg) p.o. 0.5 h before and 1 h after the injection of carrageenan
(100 μg/0.1 ml) or PBS on the left side of the scrotal tissues with a 30 G
needle, as described previously (Kubes et al., 1991). Four hours after the
carrageenan injection, mice were anesthetized by i.p. injection of a
mixture of 10 mg/kg xylazine and 200 mg/kg ketamine hydrochloride,
and the cremastermusclewas carefully dissected and exposed surgical-
ly for intravital microscopy studies as previously described (Menezes et
al., 2008). A ﬂuorescence microscope (Olympus) with a 10× objective
and a 10× eyepiece was used to examine the microcirculation in the
cremaster. A video camera (Sony, Japan) was used to project the
images onto a monitor, and the images were recorded for playback
analysis using a DVD recorder. Single unbranched cremaster venules
(25–40 μm in diameter) were selected, and to minimize variability,
the same section of cremaster venule was observed throughout the
experiment. Three 1-min ﬁlms were recorded, and the results were
expressed as the average of the analysis of the three ﬁlms. The number
of rolling and adherent leukocytes was determined ofﬂine during the
analysis of video playback.
Rolling leukocytes were deﬁned as those cells moving at a velocity
less than that of the erythrocytes within a given vessel. The ﬂux of
rolling cells was determined as the number of rolling leukocytes pass-
ing a given point in the venule per minute, and the rolling leukocyte
results were expressed as cells/min. To evaluate leukocyte adhesion,
leukocytes were considered adherent when they remained stationary
for at least 30 s. The total leukocyte adhesion was quantiﬁed as the
number of adherent cells observed within a 100-μm length of venule
in a total time of 1 min and was expressed as cells/100 μm.2.6. Histology
At the end of each intravital microscopy experiment, cremaster
muscles were removed and ﬁxed in 10% neutral buffered formalin.
The tissues were dehydrated in an ethanol series, embedded in paraf-
ﬁn, cut into 4-μm sections, stained with hematoxylin and eosin and
examined under direct light microscopy.2.7. Measurement of KC
Frozen supernatants obtained from pleural cavity washes at differ-
ent times after carrageenan or PBS challenges were used to detect KC.
For these experiments, the pleural cavities of mice treated with
nicotinamide (1000 mg/kg) 0.5 h before i.pl. carrageenan injection
(200 μg/cavity) and 0.5 h after carrageenan injection were washed
with 1.0 ml ice-cold PBS, then immediately frozen and stored at
−70 °C until the assay was performed. The presence of KC was deter-
mined with a speciﬁc KC ELISA detection kit (Peprotech, Rock Hill, NJ,
USA) according to the instructions of the manufacturer.
Fig. 1. Double p.o. nicotinamide treatment inhibits carrageenan or zymosan-induced neu-
trophil recruitment in themouse pleural cavity.Micewere treated p.o.with different doses
of nicotinamide (250–1000 mg/kg) 0.5 h before and 1 h after the i.pl. injection of carra-
geenan (200 μg/cavity) (A) or zymosan (200 μg/cavity) (B) or were post-treated 2 h
after the carrageenan i.pl. injection (C). The number of inﬁltrating neutrophils was
assessed after 4 h. CMC+PBS indicates the carboxymethylcellulose/PBS-treated group.
The results are expressed as the mean±S.E.M. of 5–6 mice/group. *Pb0.001, **Pb0.01.
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All results are presented as the mean±standard error of the mean
(S.E.M.). The results were analyzed with GraphPad Prism® 5.0 soft-
ware (San Diego, CA, USA). Groups were compared by one-way
ANOVA, and differences between groups were assessed with the
Bonferroni post-test; Pb0.05 was considered to be signiﬁcant.
3. Results
3.1. Carrageenan- or zymosan-induced neutrophil recruitment in the
mouse pleural cavity is inhibited by nicotinamide
At a dose of 1000 mg/kg, the double nicotinamide treatment (p.o.
0.5 h before and 1 h after the i.pl. injection of carrageenan or zymosan)
inhibited neutrophil recruitment 4 h after challenge (Fig. 1A). As shown
in Fig. 1B, the double nicotinamide treatment inhibited zymosan-
induced neutrophil recruitment at all nicotinamide doses. Interestingly,
p.o. administration of nicotinamide 2 h after carrageenan i.pl. injection
failed to inhibit the carrageenan-induced neutrophil recruitment
observed at 4 h after challenge (Fig. 1C). The number of mononuclear
cells in the pleural cavity of carrageenan-treated mice was not affected
by the double nicotinamide treatment (Table 1).
3.2. Nicotinamide inhibits LTB4- or IL-8-induced neutrophil recruitment
and KC production in the mouse pleural cavity
Because LTB4 is a powerful chemoattractant that is released at the
site of inﬂammation in response to inﬂammatory stimuli, including
carrageenan (Mathieu et al., 1990), we investigated the ability of the
double p.o. nicotinamide treatment to inhibit LTB4-induced neutrophil
recruitment in the pleurisy model. The double p.o. nicotinamide treat-
ment signiﬁcantly suppressed (by 87.5%) the recruitment of neutro-
phils to the pleural cavities of mice at 4 h after the administration of
LTB4 (Fig. 2A).
LTB4 appears to mediate the recruitment of neutrophils by acting
directly on receptors present on the neutrophil surface (Goldman
and Goetzl, 1982) and through the production of the CXC chemokine
KC/IL-8. Therefore, we examined whether the double p.o. nicotinamide
treatment played a role in inhibiting IL-8-induced neutrophil recruit-
ment and whether nicotinamide could inhibit the release of KC in
carrageenan-induced pleurisy. As shown in Fig. 2B, IL-8-induced neu-
trophil recruitment was signiﬁcantly inhibited by the double p.o. nico-
tinamide treatment. Indeed, KC was detected at an early stage (0.5 h)
in the supernatants obtained from the pleural cavities of carrageenan-
injected mice, and the double p.o. nicotinamide treatment inhibited
KC production at 0.5 h (Fig. 3A, carboxymethylcellulose+PBS: 0.09±
0.035 ng/ml; carboxymethylcellulose+carrageenan: 0.5±0.035 ng/ml;
nicotinamide+carrageenan: 0.2±0.043 ng/ml). Double p.o. nicotin-
amide treatment failed to inhibit KC production 2 h after the i.pl.
carrageenan injection (Fig. 3B, carboxymethylcellulose + PBS: 0.2±
0.09 ng/ml; carboxymethylcellulose + carrageenan: 1.0 ± 0.15 ng/ml;
nicotinamide+carrageenan: 0.6±0.08 ng/ml).
3.3. Nicotinamide abolished the number of rolling and adhering
neutrophils on the vessel wall
To assess and separately study the effects of double nicotinamide
treatment on leukocytes in the microcirculation, a cremaster prepara-
tion was visualized by ﬂuorescence microscopy. Histological analysis
of the microvasculature in the cremaster muscles revealed that
there are very few leukocytes surrounding the blood vessel in PBS-
injected mice (Fig. 4A), while the number of leukocytes surrounding
the vessels increases after carrageenan injection (Fig. 4B). By contrast,
the number of leukocytes in the microcirculation was inhibited
after double p.o. treatment of mice with nicotinamide (Fig. 4C). Thenumber of adherent leukocytes and rolling cells in the microcircula-
tion in the cremaster muscle preparation was reduced following
nicotinamide treatment in carrageenan-treated mice (Fig. 5). These
Table 1
Total and differential cell counts (×103/cavity) in response to i.pl. injection of carra-
geenan in mice treated with different doses of nicotinamide.
CMC+
PBS
Carrageenan 200 μg /cavity
CMC Nicotinamide (mg/kg)
250 500 1000
Total 7.7±2.0 33.7±6.0a 45.4±9.3 26.0±4.4 11.1±0.5
Neutrophils 1.9±0.6 27.1±5.6b 35.3±7.3 19.7±3.9 5.4±0.6c
Macrophages 5.7±1.5 6.5±0.8 10.0±2.1 6.3±0.6 5.6±0.9
The results are expressed as the mean±S.E.M. of 5 mice/group.
a Pb0.05 when compared to CMC+PBS-treated group.
b Pb0.001 when compared to CMC+PBS-treated group.
c Pb0.001 when compared to CMC+carrageenan-treated group. CMC+PBS
indicates the carboxymethylcellulose/PBS-treated group.
201R.G. Ferreira et al. / European Journal of Pharmacology 685 (2012) 198–204results are in agreement with the effects of nicotinamide treatment
on neutrophil migration in carrageenan-induced pleurisy.
4. Discussion
The role of neutrophils in the pathophysiology of inﬂammatory dis-
eases is well established, with many lines of evidence supporting a di-
rect correlation between the presence of neutrophils at the inﬂamed
tissue and the progression of inﬂammatory diseases (Faurschou and
Borregaard, 2003; Kobayashi and DeLeo, 2009; Weiss, 1989). It is thus
hypothesized that drugs that inhibit neutrophil recruitment and/or ac-
tivation may become important in new therapeutic strategies for the
treatment of inﬂammatory diseases.Fig. 2. Effects of nicotinamide double p.o. treatment in response to LTB4 or IL-8 injection
into the mouse pleural cavity.Mice were treated p.o. with nicotinamide (1000 mg/kg)
0.5 h before and 1 h after the i.pl. injection of LTB4 (500 ng/cavity) (A) or IL-8 (60 ng/
cavity) (B), and the number of inﬁltrating neutrophils was assessed after 4 h. CMC+PBS
indicates the carboxymethylcellulose/PBS-treated group. The results are expressed as
the mean±S.E.M. of 6–10 mice/group; *Pb0.001.
Fig. 3. KC production is inhibited in the pleural cavity following the injection of carrageen-
an in double per os-treated mice.Mice were treated p.o. with nicotinamide (1000 mg/kg)
0.5 h before i.pl. carrageenan injection (200 μg/cavity), and 0.5 h (panel A) or 2 h (panel B)
after carrageenan injection, the pleural cavities of mice were washed, the cells were re-
moved by centrifugation, and the supernatants were used for the determination of KC
with a commercially available ELISA. CMC+PBS indicates the carboxymethylcellulose/
PBS-treated group. The results are expressed as the mean±S.E.M. of 3 mice/group;
*Pb0.001; **Pb0.01.There are several experimental studies that support an anti-
inﬂammatory role for nicotinamide and other vitamin B components.
Most of this evidence has been based on the shared ability of these
molecules to inhibit PARP-1, impairing the transcription of pro-
inﬂammatory genes and down-regulating pathways of inﬂammation
and tissue injury (Sodhi et al., 2010), and reduce NF-κB activation
(Crowley et al., 2000; Grange et al., 2009; Pero et al., 1999),
decreasing the production of the inﬂammatory cytokines IL-1β, TNF-α
(Fukuzawa et al., 1997), IL-6, and IL-8 (Ungerstedt et al., 2003) and
lipid mediators such as PGE2 (Sanchez-Fidalgo et al., 2007). Moreover,
PARP-1-deﬁcient mice exhibit decreased transcription and expression
of IL-1β, monocyte chemotactic protein (MCP)-1, and TNF-α (Ba and
Garg, 2011).
However, to date, a pharmacological approach for the treatment of
inﬂammatory diseases based on nicotinamide administration has
not been developed, and the mechanisms involved in the anti-
inﬂammatory activities of nicotinamide are not yet fully understood.
Moreover, the effects of nicotinamide on the recruitment of leuko-
cytes require further clariﬁcation. In the present study, we investigat-
ed the ability of nicotinamide to inhibit neutrophil recruitment in the
pleural cavity of mice in response to different inﬂammatory stimuli.
We focused on the ability of nicotinamide to inhibit neutrophil migra-
tion in carrageenan-induced pleurisy in mice and the rolling and ad-
hesion of neutrophils on the vessel wall in response to carrageenan.
Fig. 4. Histology of the microvasculature in cremaster muscles obtained from double
p.o. nicotinamide-treated mice.Mice were treated p.o. with nicotinamide (1000 mg/kg)
0.5 h before and 1 h after the injection of carrageenan (100 μg/0.1 ml) in the left side of
the scrotal tissues. The cremaster muscles were removed 4 h after carrageenan injection
and ﬁxed in 10% neutral buffered formalin. The tissues were dehydrated in an ethanol
series, embedded in parafﬁn, cut into 4-μm sections, stained with hematoxylin and
eosin and examined under direct light microscopy (200×). Panels A, B, and C represent
the histological preparations obtained from carboxymethylcellulose+PBS-treated mice,
carboxymethylcellulose+carrageenan-treated mice, or nicotinamide+carrageenan-
treated mice, respectively. Ve = vessel and Lc = leukocyte.
Fig. 5. Nicotinamide treatment reduces thenumber of rolling and adhesion neutrophils on
the vessel wall of mouse cremaster muscles. Mice were treated p.o. with nicotinamide
(1000 mg/kg) 0.5 h before and 1 h after the injection of carrageenan (100 μg/0.1 ml) in
the left side of the scrotal tissues. The number of adherent (A) and rolling (B) leukocytes
was determined using ﬂuorescence microscopy 4 h after carrageenan injection. CMC+
PBS indicates the carboxymethylcellulose/PBS-treated group. The results are expressed
as the mean±S.E.M. of 3–4 mice/group; *Pb0.05; **Pb0.001.
202 R.G. Ferreira et al. / European Journal of Pharmacology 685 (2012) 198–204The initial experiments were designed to investigate the ability of
nicotinamide to inhibit carrageenan- or zymosan-induced neutrophil
recruitment in a mouse pleurisy model. The doses of nicotinamide
used were based on previous studies with nicotinic acid (Brown et
al., 1981; Wang et al., 1990), and the treatment protocol utilizedwas based on a previous study by Nagai et al. (Nagai et al., 1994). In
the present study, nicotinamide effectively inhibited carrageenan-
induced neutrophil migration when administered twice, i.e., 30 min
before and 1 h after carrageenan challenge. However, a single admin-
istration of nicotinamide at 2 h after carrageenan challenge failed to
inhibit carrageenan-induced neutrophil recruitment into the mouse
pleural cavity, suggesting that nicotinamide is ineffective in inhibiting
neutrophil recruitment when the inﬂammatory process has been
established. These results are in accordance with previous studies in
a bleomycin-induced inﬂammation model in hamsters, in which nic-
otinic acid treatment reduced bleomycin-induced neutrophil accu-
mulation in the lungs. Interestingly, in these experiments, nicotinic
acid treatment signiﬁcantly decreased bleomycin-induced lung
PARP activity (Brown et al., 1981). Indeed, PARP treatment with nic-
otinamide or with PARP inhibitor 3-aminobenzamide (3-AB) inhib-
ited neutrophil inﬁltration in the paws of rats in zymosan-activated
plasma-induced paw edema (Cuzzocrea et al., 1999a) and leukocyte
inﬁltration in carrageenan-induced pleurisy in rats (Cuzzocrea et al.,
1999b).
Carrageenan is a well-known inﬂammatory stimulus that is utilized
in in vivo studies of neutrophil migration and elicits the production of
inﬂammatory mediators, including the chemoattractants molecules
LTB4 and IL-8/KC, which in turn contribute to the development and
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amide was effective in inhibiting the production of KC, whenmeasured
30 min after carrageenan injection.
Because LTB4 and IL-8/KC mediate murine neutrophil recruitment
via the activation of receptors present on the surface of neutrophils
(Okuno et al., 2005; Yokomizo et al., 1997) and carrageenan has been
shown to stimulate tissue cells and leukocytes to release these
chemoattractant molecules (Saleh et al., 1999), experiments were per-
formed to investigate whether nicotinamide was also effective in inhi-
biting neutrophil recruitment in response to these chemoattractants.
Nicotinamide treatment inhibited neutrophil recruitment induced by
i.pl. injection of LTB4 or IL-8. These results demonstrate the ability of
nicotinamide to inhibit the action of these chemotactic molecules that
are released in turn at the inﬂammatory site during early inﬂammation,
suggesting that the effects of nicotinamide on neutrophil recruitment
may be due to the control of early events related to neutrophil migra-
tion, such as the impairment of neutrophil chemoattractant molecules.
Interestingly, nicotinamide appears to be more potent in inhibiting
zymosan-induced neutrophil recruitment than carrageenan-induced
pleurisy because lower doses of nicotinamide were required to inhibit
neutrophil recruitment in response to zymosan. Zymosan leads to the
activation of the complement system cascade and the subsequent pro-
duction of anaphylatoxins, chemoattractants to neutrophils (Camussi
et al., 1980). Thus, the inhibition of the complement systemmay be in-
volved in the inhibitory effects of nicotinamide on zymosan-induced
neutrophil recruitment, supporting an additional role for nicotinamide
action during the initial phase of events that promote leukocyte migra-
tion from the blood vessels into the tissues.
We have demonstrated that nicotinamide treatment abolished the
rolling and adherence of neutrophils, thereby impairing the ability of
neutrophils to migrate from blood vessels into tissues. Our intravital
results are in agreement with studies by Von Lukowicz et al. (2008)
in which the pharmacological inhibition of PARP-1 enzymatic activ-
ity and the genetic deletion of PARP-1 reduced the expression of vas-
cular cell adhesion molecule (VCAM)-1 and P- and E-selectin (von
Lukowicz et al., 2008). We speculate that in the carrageenan model,
nicotinamide may act through the down-regulation of the expression
of adhesionmolecules necessary for the induction of neutrophil efﬂux
from blood vessels into the tissues; however, additional studies are
needed to conﬁrm this hypothesis.5. Conclusion
In conclusion, we demonstrate a key role for nicotinamide in inhi-
biting neutrophil recruitment in a mouse pleurisy model. Taken to-
gether, our results strongly indicate that the effects of nicotinamide
in inhibiting neutrophil recruitment in carrageenan-induced pleurisy
may be explained by their ability to inhibit the action of IL-8 and LTB4,
decrease KC production, and impair early events that regulate the ad-
hesion and rolling of leukocytes in the microcirculation.Acknowledgments
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